2020
DOI: 10.1111/odi.13398
|View full text |Cite
|
Sign up to set email alerts
|

Neuropathy complication of antiretroviral therapy in HIV/AIDS patients

Abstract: Objectives Significant pain from HIV‐associated sensory neuropathy (HIV‐SN) affects 40% of HIV‐infected individuals treated with antiretroviral therapy (ART). The most salient symptom of the neuropathy is pain, which frequently is moderate‐to‐severe intensity, associated with reduced activities and physical function, sleep disruption, increased severity of depression, and anxiety. Yet, evidence for managing painful HIV‐SN is poor. The purpose of this study was to verify by scientific evidence the neuropathy co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 25 publications
0
3
0
1
Order By: Relevance
“…Indeed, ART has a direct effect on the bone metabolism by exacerbating bone loss (with a reported 2-6% loss in BMD) at the femora, lumbar spine, and hips; which are sites susceptible to fractures [173,179,183]. Lastly, neuropathy may be another potential complication of ART [184,185], which may indirectly impact the skeletal system by leading to conditions such as neuropathic arthropathy (Charcot joint) [186,187].…”
Section: Antiretroviral Therapymentioning
confidence: 99%
“…Indeed, ART has a direct effect on the bone metabolism by exacerbating bone loss (with a reported 2-6% loss in BMD) at the femora, lumbar spine, and hips; which are sites susceptible to fractures [173,179,183]. Lastly, neuropathy may be another potential complication of ART [184,185], which may indirectly impact the skeletal system by leading to conditions such as neuropathic arthropathy (Charcot joint) [186,187].…”
Section: Antiretroviral Therapymentioning
confidence: 99%
“…Nearly 40% of these patients suffering from HIV develop HIV-associated neuropathy which is also referred to as HIV-distal symmetrical polyneuropathy (HIV-DSP) [ 4 ]. Human immunodeficiency virus-distal symmetrical polyneuropathy in patients can be attributed to the effects of post-anti-retroviral therapy (ART) or the chronicity and debilitation of the condition itself [ 1 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Nearly 40% of these patients suffering from HIV develop HIV-associated neuropathy which is also referred to as HIV-distal symmetrical polyneuropathy (HIV-DSP) [ 4 ]. Human immunodeficiency virus-distal symmetrical polyneuropathy in patients can be attributed to the effects of post-anti-retroviral therapy (ART) or the chronicity and debilitation of the condition itself [ 1 , 4 ]. There have been several studies exploring other neurological phenomena associated with HIV such as autonomic neuropathy, peripheral facial paralysis (PFP), and neurocognitive difficulties [ 5 - 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…One-third of those diagnosed with HIV/AIDS are reported to have peripheral neuropathies that can be caused by the virus itself, opportunistic infections, or as a side effect of some drugs used [8] . Nondepolarizing neuromuscular blocking agents bind competitively to the nicotinic acetylcholine receptor (AchR) on the peripheral neuromuscular junction, blocking the ability of acetylcholine to produce depolarization and leading to flaccid paralysis [9] .…”
Section: Introductionmentioning
confidence: 99%